RADIOPHARMACEUTICALS FOR THERAPEUTIC MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST

2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS

  2.1.1 MARKET DRIVER ANALYSIS

  2.1.2 MARKET RESTRAINT ANALYSIS

  2.1.3 MARKET OPPORTUNITY

  2.1.4 MARKET CHALLENGES

3.1 INDUSTRY TRENDS

  3.1.1 SWOT ANALYSIS

  3.1.2 PESTEL ANALYSIS

  3.1.3 PORTER’S FIVE FORCES ANALYSIS

3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS

4.1 COVID-19 ANALYSIS

5.1 GLOBAL RADIOPHARMACEUTICALS FOR THERAPEUTIC MARKET, SALES AREA, TYPE

5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL RADIOPHARMACEUTICALS FOR THERAPEUTIC MARKET

7.1 GLOBAL RADIOPHARMACEUTICALS FOR THERAPEUTIC MARKET SIZE AND SHARE (2018-2031) (USD MILLION)

8.1 GLOBAL RADIOPHARMACEUTICALS FOR THERAPEUTIC MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

8.2 GLOBAL RADIOPHARMACEUTICALS FOR THERAPEUTIC MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

9.1 GLOBAL RADIOPHARMACEUTICALS FOR THERAPEUTIC MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

9.2 GLOBAL RADIOPHARMACEUTICALS FOR THERAPEUTIC MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

10.1 GLOBAL RADIOPHARMACEUTICALS FOR THERAPEUTIC MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)

10.2 GLOBAL RADIOPHARMACEUTICALS FOR THERAPEUTIC MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)

11.1 NORTH AMERICA RADIOPHARMACEUTICALS FOR THERAPEUTIC MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

11.2 NORTH AMERICA RADIOPHARMACEUTICALS FOR THERAPEUTIC MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

11.3 NORTH AMERICA RADIOPHARMACEUTICALS FOR THERAPEUTIC MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

11.4 NORTH AMERICA RADIOPHARMACEUTICALS FOR THERAPEUTIC MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

11.5 NORTH AMERICA RADIOPHARMACEUTICALS FOR THERAPEUTIC MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

11.6 NORTH AMERICA RADIOPHARMACEUTICALS FOR THERAPEUTIC MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

12.1 EUROPE RADIOPHARMACEUTICALS FOR THERAPEUTIC MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

12.2 EUROPE RADIOPHARMACEUTICALS FOR THERAPEUTIC MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

12.3 EUROPE RADIOPHARMACEUTICALS FOR THERAPEUTIC MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

12.4 EUROPE RADIOPHARMACEUTICALS FOR THERAPEUTIC MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

12.5 EUROPE RADIOPHARMACEUTICALS FOR THERAPEUTIC MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

12.6 EUROPE RADIOPHARMACEUTICALS FOR THERAPEUTIC MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

13.1 ASIA PACIFIC RADIOPHARMACEUTICALS FOR THERAPEUTIC MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

13.2 ASIA PACIFIC RADIOPHARMACEUTICALS FOR THERAPEUTIC MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

13.3 ASIA PACIFIC RADIOPHARMACEUTICALS FOR THERAPEUTIC MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

13.4 ASIA PACIFIC RADIOPHARMACEUTICALS FOR THERAPEUTIC MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

13.5 ASIA PACIFIC RADIOPHARMACEUTICALS FOR THERAPEUTIC MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

13.6 ASIA PACIFIC RADIOPHARMACEUTICALS FOR THERAPEUTIC MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

14.1 LATIN AMERICA RADIOPHARMACEUTICALS FOR THERAPEUTIC MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>

14.2 LATIN AMERICA RADIOPHARMACEUTICALS FOR THERAPEUTIC MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

14.3 LATIN AMERICA RADIOPHARMACEUTICALS FOR THERAPEUTIC MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

14.4 LATIN AMERICA RADIOPHARMACEUTICALS FOR THERAPEUTIC MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

14.5 LATIN AMERICA RADIOPHARMACEUTICALS FOR THERAPEUTIC MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

14.6 LATIN AMERICA RADIOPHARMACEUTICALS FOR THERAPEUTIC MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

15.1 MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS FOR THERAPEUTIC MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

15.2 MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS FOR THERAPEUTIC MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

15.3 MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS FOR THERAPEUTIC MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

15.4 MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS FOR THERAPEUTIC MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

15.5 MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS FOR THERAPEUTIC MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

15.6 MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS FOR THERAPEUTIC MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>

16.1 Bayer

  16.1.1 COMPANY DETAILS

  16.1.2 FINANCIALS (USD MILLION)

  16.1.3 PRODUCT SUMMARY

  16.1.4 RECENT DEVELOPMENTS

16.2 Novartis

16.3 China Isotope & Radiation

16.4 Dongcheng

16.5 Q BioMed

16.6 Curium Pharmaceuticals

16.7 Jubilant DraxImage

16.8 Lantheus

16.9 Spectrum Pharmaceuticals

16.10 Progenics Pharmaceuticals

16.11 International Isotopes

18.1 METHODOLOGY

18.2 RESEARCH DATA SOURCE

  18.2.1 SECONDARY DATA

  18.2.2 KEY DATA FROM SECONDARY

  18.2.3 PRIMARY DATA

  18.2.4 KEY DATA FROM PRIMARY

  18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS

  18.2.6 MARKET ESTIMATION

  18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH

  18.2.8 LEGAL DISCLAIMER